CPRX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

7.07

Margin Of Safety %

Put/Call OI Ratio

0.5

EPS Next Q Diff

0.23

EPS Last/This Y

1.11

EPS This/Next Y

0.28

Price

31.27

Target Price

32.62

Analyst Recom

2.5

Performance Q

29.66

Upside

94.8%

Beta

0.74

Ticker: CPRX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-23	CPRX	27.68	0.62	0.01	9251
2026-04-24	CPRX	27.38	0.49	0.00	10810
2026-04-27	CPRX	29.26	0.42	0.05	12027
2026-04-28	CPRX	29.43	0.37	0.27	13447
2026-04-29	CPRX	28.26	0.37	0.32	13581
2026-04-30	CPRX	28.14	0.38	0.02	13420
2026-05-01	CPRX	28.73	0.38	0.02	13337
2026-05-04	CPRX	28.92	0.38	0.13	13371
2026-05-05	CPRX	30.86	0.38	0.01	13356
2026-05-06	CPRX	30.52	0.37	0.12	13625
2026-05-07	CPRX	31.16	0.37	0.08	13693
2026-05-08	CPRX	31.16	0.35	0.14	14446
2026-05-11	CPRX	31.15	0.36	0.06	14081
2026-05-12	CPRX	31.14	0.33	0.21	15230
2026-05-13	CPRX	31.16	0.33	0.03	15056
2026-05-14	CPRX	31.15	0.35	0.01	14545
2026-05-15	CPRX	31.18	0.34	0.00	14730
2026-05-18	CPRX	31.23	0.49	0.03	8450
2026-05-19	CPRX	31.22	0.48	0.00	8635
2026-05-20	CPRX	31.25	0.47	0.60	8708
2026-05-21	CPRX	31.29	0.50	0.01	8670
2026-05-22	CPRX	31.26	0.50	0.01	8618
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-23	CPRX	27.69	-6.6	46.7	2.85
2026-04-24	CPRX	27.37	-6.6	18.3	2.85
2026-04-27	CPRX	29.27	-6.6	47.1	2.85
2026-04-28	CPRX	29.43	-6.6	24.3	2.85
2026-04-30	CPRX	28.12	-6.6	20.7	2.85
2026-05-01	CPRX	28.72	-6.6	29.8	2.85
2026-05-04	CPRX	28.92	-6.6	24.6	2.85
2026-05-05	CPRX	30.87	-5.5	45.7	2.86
2026-05-06	CPRX	30.51	-5.5	18.3	2.86
2026-05-07	CPRX	31.17	-5.5	29.8	2.86
2026-05-08	CPRX	31.16	-5.5	22.5	2.86
2026-05-11	CPRX	31.14	-5.5	22.2	2.86
2026-05-12	CPRX	31.14	-5.5	22.4	2.86
2026-05-13	CPRX	31.16	-5.5	12.7	2.86
2026-05-14	CPRX	31.15	-5.5	12.4	2.86
2026-05-15	CPRX	31.17	-5.5	12.7	2.86
2026-05-18	CPRX	31.22	1.8	12.9	2.86
2026-05-19	CPRX	31.23	1.8	12.6	2.86
2026-05-20	CPRX	31.25	1.8	13.0	2.86
2026-05-21	CPRX	31.28	1.8	12.9	2.86
2026-05-22	CPRX	31.27	1.8	12.3	2.86
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-23	CPRX	-0.30	1.16	8.33
2026-04-24	CPRX	-0.30	1.16	8.33
2026-04-27	CPRX	-0.30	1.19	7.75
2026-04-28	CPRX	-0.30	1.19	7.75
2026-04-29	CPRX	-0.30	1.19	7.75
2026-04-30	CPRX	-0.30	1.19	7.75
2026-05-01	CPRX	-0.30	1.19	7.75
2026-05-04	CPRX	-0.30	1.31	7.75
2026-05-05	CPRX	-0.30	1.31	7.75
2026-05-06	CPRX	-0.30	1.31	7.75
2026-05-07	CPRX	-0.30	1.31	7.73
2026-05-08	CPRX	-0.30	1.31	7.73
2026-05-11	CPRX	-0.30	1.74	7.73
2026-05-12	CPRX	-0.30	1.74	7.14
2026-05-13	CPRX	-0.30	1.74	7.14
2026-05-14	CPRX	-0.30	1.74	7.14
2026-05-15	CPRX	-0.30	1.74	7.14
2026-05-18	CPRX	-0.30	2.67	7.13
2026-05-19	CPRX	-0.30	2.67	7.13
2026-05-20	CPRX	-0.30	2.67	7.13
2026-05-21	CPRX	-0.30	2.67	7.07
2026-05-22	CPRX	-0.33	2.67	7.07
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.5

Avg. EPS Est. Current Quarter

0.69

Avg. EPS Est. Next Quarter

0.73

Insider Transactions

-0.33

Institutional Transactions

2.67

Beta

0.74

Average Sales Estimate Current Quarter

153

Average Sales Estimate Next Quarter

160

Fair Value

32.01

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-45.4

Target Price

32.62

P/E

17.97

Forward P/E

13.96

PEG

1.4

P/S

6.41

P/B

3.77

P/Free Cash Flow

18.38

EPS

1.74

Average EPS Est. Cur. Y

2.86

EPS Next Y. (Est.)

3.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

37.08

Relative Volume

0.94

Return on Equity vs Sector %

-5.2

Return on Equity vs Industry %

10.4

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

12.3

◆ CPRX Healthcare

$31.26

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

8/25

Volume

7/15

Valuation

9/20

TP/AR

1/10

Options

7/10

RSI

73.4

Range 1M

80.4%

Sup Dist

0.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

14/30

Estimates

6/20

Inst/Vol

9/15

Options

7/10

EPS Yr

14.4%

EPS NY

16.5%

52W%

90.3%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +127.4% upside

Quality

25/30

Valuation

20/30

Growth

13/25

Stability

8/10

LT Trend

1/5

Upside

+127.4%

Quality

MoS

Catalyst Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 182

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizure; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

CPRX

Latest News

—

Caricamento notizie per CPRX…

stock quote shares CPRX – Catalyst Pharmaceuticals, Inc. Stock Price stock today

news today CPRX – Catalyst Pharmaceuticals, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CPRX – Catalyst Pharmaceuticals, Inc. yahoo finance google finance

stock history CPRX – Catalyst Pharmaceuticals, Inc. invest stock market

stock prices CPRX premarket after hours

ticker CPRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CPRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y